These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 20559756)

  • 1. New antituberculous drugs in development.
    Lalloo UG; Ambaram A
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):143-51. PubMed ID: 20559756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present and future in the use of anti-tubercular drugs].
    Didilescu C; Craiova UM
    Pneumologia; 2011; 60(4):198-201. PubMed ID: 22420168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs and regimens for treatment of TB.
    Leibert E; Rom WN
    Expert Rev Anti Infect Ther; 2010 Jul; 8(7):801-13. PubMed ID: 20586565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis pharmacotherapy: strategies to optimize patient care.
    Mitnick CD; McGee B; Peloquin CA
    Expert Opin Pharmacother; 2009 Feb; 10(3):381-401. PubMed ID: 19191677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
    Tasneen R; Li SY; Peloquin CA; Taylor D; Williams KN; Andries K; Mdluli KE; Nuermberger EL
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5485-92. PubMed ID: 21930883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMC207: the first compound of a new class of potent anti-tuberculosis drugs.
    Matteelli A; Carvalho AC; Dooley KE; Kritski A
    Future Microbiol; 2010 Jun; 5(6):849-58. PubMed ID: 20521931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
    Deshpande D; Srivastava S; Nuermberger E; Pasipanodya JG; Swaminathan S; Gumbo T
    Clin Infect Dis; 2016 Nov; 63(suppl 3):S95-S101. PubMed ID: 27742640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of tuberculosis.
    Zhang Y
    Clin Pharmacol Ther; 2007 Nov; 82(5):595-600. PubMed ID: 17898708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 12. Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.
    de Knegt GJ; van der Meijden A; de Vogel CP; Aarnoutse RE; de Steenwinkel JE
    Int J Antimicrob Agents; 2017 Mar; 49(3):302-307. PubMed ID: 28162983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment options for multidrug-resistant tuberculosis.
    Field SK; Fisher D; Jarand JM; Cowie RL
    Ther Adv Respir Dis; 2012 Oct; 6(5):255-68. PubMed ID: 22763676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public-private partnership tackles TB challenges in parallel.
    Webb S
    Nat Rev Drug Discov; 2009 Aug; 8(8):599-600. PubMed ID: 19644463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis: clinical trials and new drug regimens.
    Kwon YS; Jeong BH; Koh WJ
    Curr Opin Pulm Med; 2014 May; 20(3):280-6. PubMed ID: 24614239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tuberculosis therapeutics: a growing pipeline.
    Spigelman MK
    J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel agents in the management of Mycobacterium tuberculosis disease.
    Barry PJ; O'Connor TM
    Curr Med Chem; 2007; 14(18):2000-8. PubMed ID: 17691942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy.
    Sgaragli G; Frosini M; Saponara S; Corelli F
    Curr Med Chem; 2016; 23(21):2245-74. PubMed ID: 27142291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.